Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly  Settings
CAPS [NASD]
Capstone Therapeutics Corp.
Healthcare | Biotechnology | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.27 Insider Own0.79% Shs Outstand40.78M Perf Week10.42%
Market Cap8.56M Forward P/E- EPS next Y- Insider Trans87.13% Shs Float39.59M Perf Month-0.10%
Income-11.16M PEG- EPS next Q- Inst Own26.56% Short Float0.07% Perf Quarter-0.10%
Sales0.00M P/S- EPS this Y17.16% Inst Trans-8.33% Short Ratio1.38 Perf Half Y39.87%
Book/sh0.50 P/B0.42 EPS next Y- ROA-39.74% Target Price- Perf Year23.41%
Cash/sh0.53 P/C0.40 EPS next 5Y- ROE-42.55% 52W Range0.12 - 0.26 Perf YTD23.41%
Dividend- P/FCF- EPS past 5Y- ROI-42.55% 52W High-19.31% Beta0.41
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low74.83% ATR0.01
Employees22 Current Ratio12.67 Sales Q/Q- Oper. Margin- RSI (14)56.17 Volatility3.79% 5.14%
OptionableNo Debt/Eq0.00 EPS Q/Q-9.70% Profit Margin- Rel Volume0.03 Prev Close0.18
ShortableYes LT Debt/Eq0.00 EarningsMay 15 Payout- Avg Volume19.31K Price0.21
Recom- SMA208.14% SMA500.29% SMA20017.60% Volume500 Change16.56%
15-May-13 09:30AM  Capstone Therapeutics Will Provide an Operating Update and Announces First Quarter 2013 Financial Results GlobeNewswire -5.26%
07:07AM  Q1 2013 Capstone Therapeutics Earnings Release - Time Not Supplied CCBN
02:32AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu EDGAR Online
02:31AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online
08-May-13 09:00AM  Capstone Therapeutics to Hold Operating Update Conference Call GlobeNewswire +5.56%
19-Mar-13 01:04PM  CAPSTONE THERAPEUTICS CORP. Financials EDGAR Online Financials -9.09%
14-Mar-13 08:16AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu EDGAR Online
08:15AM  Capstone Therapeutics Will Provide an Operating Update and Announces 2012 Financial Results GlobeNewswire
08:02AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-K, Annual Report EDGAR Online
07-Mar-13 11:00AM  Capstone Therapeutics to Hold Operating Update Conference Call GlobeNewswire
06-Dec-12 12:28PM  FDA grants AEM-28 Orphan Drug designation for the treatment of HoFH at theflyonthewall.com +14.29%
12:20PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
12:10PM  Apolipoprotein E Mimetic Peptide AEM-28 Granted Orphan Drug Designation for the Treatment of Homozygous Familial Hypercholesterolemia GlobeNewswire
22-Nov-12 01:04PM  CAPSTONE THERAPEUTICS CORP. Financials EDGAR Online Financials
08-Nov-12 11:32AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu EDGAR Online
11:01AM  Capstone Therapeutics Will Provide an Operating Update and Announces Third Quarter 2012 Financial Results GlobeNewswire
10:29AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online
02-Nov-12 12:05PM  Capstone Therapeutics to Hold Quarterly Update Conference Call GlobeNewswire +6.67%
21-Sep-12 10:25AM  5 Stocks Trading Below Net Cash - Part VIII at Seeking Alpha
03-Sep-12 03:34AM  5 Stocks Trading Below Net Cash - Part VIII at Seeking Alpha
18-Aug-12 01:04PM  CAPSTONE THERAPEUTICS CORP. Financials EDGAR Online Financials
10-Aug-12 01:21PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online +6.25%
08:31AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online
08-Aug-12 12:01PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosu EDGAR Online -15.79%
03-Aug-12 04:06PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition EDGAR Online
04:01PM  Capstone Therapeutics Enters Into a Joint Venture for the Development of Apo E Mimetic Peptide AEM-28 and Analogs and Announces Conference Call GlobeNewswire
18-Jun-12 01:15PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online -11.11%
15-Jun-12 09:32AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online +12.50%
24-May-12 01:05PM  CAPSTONE THERAPEUTICS CORP. Financials EDGAR Online Financials
10-May-12 08:04AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online
21-Mar-12 08:32AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-K, Annual Report EDGAR Online -12.50%
08:30AM  Capstone Therapeutics Provides Operating Update and Announces 2011 Financial Results GlobeNewswire
20-Jan-12 08:01AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, EDGAR Online
10-Nov-11 09:02AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online -7.69%
14-Oct-11 04:34PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, EDGAR Online
23-Aug-11 08:01AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
12-Aug-11 08:01AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online
25-Jul-11 08:30AM  Insiders Trading ILMN, CAPS and MTG at TheStreet
20-Jul-11 06:03AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or EDGAR Online
06-Jul-11 08:03AM  Capstone Therapeutics announces AZX100 preclinical results theflyonthewall.com
08:01AM  InPlay: Capstone Therapeutics announces pre-clinical results with AZX100 in radiation and bleomycin models of pulmonary fibrosis; pulmonary anti-fibrotic effect demonstrated Briefing.com
08:00AM  Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; Pulmonary Anti-Fibrotic Effect Demonstrated GlobeNewswire
01-Jul-11 02:12PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events EDGAR Online
17-Jun-11 05:22PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Other Events EDGAR Online
08-Jun-11 12:42PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to EDGAR Online
12:30PM  Capstone Therapeutics Announces Adjournment of Its Annual Meeting of Stockholders and Intention to Reconvene the Meeting on June 28, 2011 GlobeNewswire
06-Jun-11 08:01AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
31-May-11 02:02PM  InPlay: Capstone Therapeutics signs alliance with BiolineRx to develop Chrysalin in Acute Myocardial Infarction Briefing.com
02:00PM  Capstone Therapeutics Signs Alliance With BiolineRx to Develop Chrysalin (TP508) in Acute Myocardial Infarction GlobeNewswire
26-May-11 05:00PM  Capstone Therapeutics Reminds Stockholders of Annual Meeting on June 6, 2011 and Encourages All Stockholders to Vote GlobeNewswire
18-May-11 01:04PM  CAPSTONE THERAPEUTICS CORP. Financials EDGAR Online Financials
13-May-11 09:00AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online
12-May-11 09:01AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or EDGAR Online
09-May-11 12:22PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or EDGAR Online
28-Apr-11 06:05PM  Nasdaq stocks posting largest volume increases AP
27-Apr-11 04:45PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhi EDGAR Online
04:45PM  InPlay: Capstone Therapeutics confirms early signal of AZX100 effect based on final results of Phase 2a pilot clinical trial in surgical (trocar site) scarring Briefing.com
04:45PM  Capstone Therapeutics Confirms Early Signal of AZX100 Effect Based on Final Results of Phase 2a Pilot Clinical Trial in Surgical (Trocar Site) Scarring GlobeNewswire
04-Apr-11 04:14PM  InPlay: Capstone Therapeutics delays results from its AZX100 Phase 2a pilot clinical trial Briefing.com
04:05PM  Capstone Therapeutics Announces Update to Timing of Release of Final Results From AZX100 Phase 2a Pilot Clinical Trial in Surgical (Trocar Site) Scarring GlobeNewswire
01-Apr-11 01:04PM  CAPSTONE THERAPEUTICS CORP. Financials EDGAR Online Financials
29-Mar-11 02:37PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Other Events EDGAR Online
09:02AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-K, Annual Report EDGAR Online
06-Jan-11 04:52PM  Capstone Therapeutics to Present at Biotech Showcase 2011 GlobeNewswire
14-Dec-10 07:46PM  Nasdaq stocks posting largest volume increases AP
06:04AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Regulation FD Disclosure, Other Events EDGAR Online
01:09AM  InPlay: Capstone Therapeutics provides results of AZX100 Phase 2a pilot clinical trials in keloid and surgical scarring Briefing.com
13-Dec-10 09:18PM  Capstone Therapeutics Announces Results of AZX100 Phase 2a Pilot Clinical Trials in Keloid and Surgical Scarring GlobeNewswire
06:46PM  Nasdaq stocks posting largest volume increases AP
10-Dec-10 04:09AM  Capstone Therapeutics Looking to Capitalize on the Growing Dermal Market at Seeking Alpha
09-Dec-10 06:03PM  Nasdaq stocks posting largest volume increases AP
11:21AM  Stocks to Watch: Walgreens, Bank of America and More... at CNBC
08-Dec-10 05:00PM  Capstone Therapeutics to Host AZX100 Clinical Update Teleconference GlobeNewswire
13-Nov-10 01:05PM  CAPSTONE THERAPEUTICS CORP. Financials EDGAR Online Financials
12-Nov-10 01:01PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or EDGAR Online
10-Nov-10 10:00AM  Capstone Therapeutics Third Quarter 2010 Financial Results Call scheduled for 10:00 am ET today Shareholder.com
07:07AM  Q3 2010 Capstone Therapeutics Earnings Release - Time Not Supplied CCBN
06:13AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online
06:11AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 10-Q, Quarterly Report EDGAR Online
06:00AM  Capstone Therapeutics Announces Third Quarter 2010 Financial Results GlobeNewswire
03-Nov-10 09:00AM  Capstone Therapeutics to Host Quarterly Update Conference Call GlobeNewswire
01-Oct-10 07:45PM  Capstone Therapeutics to Present at 9th Annual BIO Investor Forum GlobeNewswire
13-Sep-10 01:01PM  InPlay: Capstone Therapeutics announces progress in clinical trials of AZX100 in keloid scarring Briefing.com
01:00PM  Capstone Therapeutics Announces Progress in Clinical Trials of AZX100 in Keloid Scarring GlobeNewswire
07-Sep-10 01:00PM  Capstone Therapeutics to Present at Rodman & Renshaw 12th Annual Healthcare Conference GlobeNewswire
09-Aug-10 11:00AM  Capstone Therapeutics Second Quarter 2010 Financial Results Call scheduled for 11:00 am ET today Shareholder.com
10:22AM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
07:07AM  Q2 2010 Capstone Therapeutics Earnings Release - Time Not Supplied CCBN
07:00AM  Capstone Therapeutics Announces Second Quarter 2010 Financial Results GlobeNewswire
03-Aug-10 05:00PM  Capstone Therapeutics to Host Quarterly Update Conference Call GlobeNewswire
06-Jul-10 08:00AM  Capstone Therapeutics Announces Continuation of AZX100 Phase 2 Clinical Trial in Dermal Scarring Following Shoulder Surgery GlobeNewswire
25-May-10 01:47PM  CAPSTONE THERAPEUTICS CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to EDGAR Online
24-May-10 11:00AM  Capstone Therapeutics Stockholder Update - May-2010 Call scheduled for 11:00 am ET today Shareholder.com
08:00AM  Capstone Therapeutics Corp. Appoints Robert J. Spiegel, MD to Board of Directors GlobeNewswire
21-May-10 02:07PM  Capstone Therapeutics Corp. Announces Stockholder Approval of "Put Right" and Name Change; Management to Host Conference Call GlobeNewswire
14-May-10 03:13PM  ORTHOLOGIC CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
03:00PM  Capstone Therapeutics to Present at Rodman & Renshaw 6th Annual Global Healthcare Conference GlobeNewswire
12-May-10 08:00AM  Capstone Therapeutics Announces Continuation of Second of Two AZX100 Phase 2 Clinical Trials in Keloid Scarring GlobeNewswire
07-May-10 05:25PM  ORTHOLOGIC CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T EDGAR Online
04-Apr-10 03:21AM  OSV Model Portfolio: Q1 Results at Seeking Alpha
Capstone Therapeutics Corp., a biotechnology company, develops therapeutic peptides and other molecules for helping patients with under-served medical conditions. The company focuses on the development and commercialization of two product platforms, AZX100 and Chrysalin. Its product AZX100 includes a novel synthetic 24-amino acid peptide, a class of compounds in the field of smooth muscle relaxation and fibrosis. The company involves in evaluating AZX100 for various medical applications, such as the prevention or reduction of hypertrophic and keloid scarring, treatment of pulmonary fibrosis, and vascular intimal hyperplasia. It also engages in developing Chrysalin, a novel synthetic 23-amino acid peptide for disorders that involve vascular endothelial dysfunction, including acute myocardial infarction and chronic myocardial ischemia. Capstone Therapeutics owns worldwide rights to AZX100 and Chrysalin. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is based in Tempe, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FELDMAN FREDRIC JDirectorApr 08Buy0.2125,0005,250225,564Apr 10 01:15 PM
MILLER LLOYD I III10% OwnerDec 17Buy0.16175,00028,1234,412,468Dec 18 03:47 PM
MILLER LLOYD I III10% OwnerDec 07Buy0.1697,25015,8234,237,468Dec 10 12:44 PM
MILLER LLOYD I III10% OwnerDec 06Buy0.1619,7503,2494,140,218Dec 07 12:50 PM
MILLER LLOYD I III10% OwnerNov 26Buy0.14100,00014,1004,120,468Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerNov 23Buy0.141,0001414,020,468Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerNov 21Buy0.14107,50015,1584,019,468Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerOct 19Buy0.1425,0003,5003,911,968Nov 29 04:33 PM
HOLLIMAN JOHN M IIIExecutive ChairmanOct 19Buy0.1450,0007,000482,614Oct 19 05:15 PM
HOLLIMAN JOHN M IIIExecutive ChairmanOct 18Buy0.14100,00014,000432,614Oct 19 05:15 PM
MILLER LLOYD I III10% OwnerOct 15Buy0.1495,00013,1103,886,968Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerOct 03Buy0.1334,7004,5113,791,968Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerSep 19Buy0.1433,0174,45790,344Nov 29 04:37 PM
MILLER LLOYD I III10% OwnerSep 17Buy0.1430,1024,06457,327Nov 29 04:37 PM
MILLER LLOYD I III10% OwnerSep 14Buy0.1427,2253,67527,225Nov 29 04:37 PM
MILLER LLOYD I III10% OwnerSep 13Buy0.145,0006753,757,268Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerSep 12Buy0.144,6566293,752,268Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerSep 10Buy0.14913,747,612Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerSep 07Buy0.1415,0142,0283,747,603Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerSep 06Buy0.142,5003383,732,589Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerSep 05Buy0.14104143,730,089Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerAug 30Buy0.1574,08211,1123,729,985Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerAug 29Buy0.1525,7543,8633,655,903Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerAug 28Buy0.15164253,630,149Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 27Buy0.1617,2762,6953,629,985Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 24Buy0.1619,3813,0233,612,709Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 23Buy0.164,6007183,593,328Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 22Buy0.1619,2313,0003,588,728Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 21Buy0.1620,0543,1283,569,497Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 20Buy0.1619,4583,0353,549,443Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 17Buy0.1666,00010,6263,529,985Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 15Buy0.1620,0003,2203,463,985Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 14Buy0.16100,61716,1993,443,985Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 13Buy0.16113,38318,2553,343,368Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 07Buy0.1795,00015,6753,229,985Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 06Buy0.173,5195813,134,985Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 03Buy0.163,5535763,131,466Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 02Buy0.165,7009233,127,913Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerAug 01Buy0.16208,60033,5853,122,213Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerJul 31Buy0.1631,7685,1152,913,613Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerJul 30Buy0.1614,1182,2732,881,845Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerJul 27Buy0.1610,5201,6942,867,727Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerJul 26Buy0.169,6361,5512,857,207Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerJul 25Buy0.1617,2502,7772,847,571Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerJul 24Buy0.169,0001,4492,830,321Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerJul 23Buy0.1735,9176,138472,792Nov 29 04:37 PM
MILLER LLOYD I III10% OwnerJul 18Buy0.1822,0003,850436,875Nov 29 04:37 PM
MILLER LLOYD I III10% OwnerJul 16Buy0.1823,0584,150414,875Nov 29 04:37 PM
MILLER LLOYD I III10% OwnerJul 13Buy0.1817,0003,060391,817Nov 29 04:37 PM
MILLER LLOYD I III10% OwnerJul 11Buy0.1863,00011,170374,817Nov 29 04:37 PM
MILLER LLOYD I III10% OwnerJul 06Buy0.168,7501,400311,817Nov 29 04:37 PM
MILLER LLOYD I III10% OwnerJul 05Buy0.161,114178303,067Nov 29 04:37 PM
MILLER LLOYD I III10% OwnerJul 03Buy0.1623,7503,800301,953Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJul 02Buy0.163,960634278,203Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 29Buy0.1621,7453,479274,243Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 27Buy0.1619,7473,160252,498Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 25Buy0.1618,7503,000232,751Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 22Buy0.1611,0021,760214,001Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 21Buy0.1650080202,999Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 19Buy0.165,000800202,499Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 18Buy0.165,500880197,499Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 12Buy0.155,397810191,999Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 11Buy0.1512,1271,819186,602Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 08Buy0.1510,4761,571174,475Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 07Buy0.1572,00010,800163,999Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 06Buy0.1789,79914,81791,999Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 05Buy0.171,0001652,200Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerJun 04Buy0.171,2001981,200Nov 29 04:33 PM
MILLER LLOYD I III10% OwnerMay 31Buy0.171,5002482,821,321Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerMay 30Buy0.176,5011,0732,819,821Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerMay 23Buy0.172,1403532,813,320Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerMay 22Buy0.1717,5002,8882,811,180Nov 29 04:29 PM
MILLER LLOYD I III10% OwnerMay 21Buy0.176,5001,0732,793,680Nov 29 04:29 PM
open in yahoo | open in reuters | open in google